Stephen G. Walsh

Array ( [id] => 3558838 [patent_doc_number] => 05500409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Method for inhibiting collagen synthesis by keloid fibroblasts' [patent_app_type] => 1 [patent_app_number] => 8/032714 [patent_app_country] => US [patent_app_date] => 1993-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 5634 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500409.pdf [firstpage_image] =>[orig_patent_app_number] => 032714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3489412 [patent_doc_number] => 05475101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'DNA sequence encoding endoglucanase III cellulase' [patent_app_type] => 1 [patent_app_number] => 8/032848 [patent_app_country] => US [patent_app_date] => 1993-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7022 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/475/05475101.pdf [firstpage_image] =>[orig_patent_app_number] => 032848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456479 [patent_doc_number] => 05441734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Metal-interferon-alpha crystals' [patent_app_type] => 1 [patent_app_number] => 8/024330 [patent_app_country] => US [patent_app_date] => 1993-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5424 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441734.pdf [firstpage_image] =>[orig_patent_app_number] => 024330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2990512 [patent_doc_number] => 05362492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-08 [patent_title] => 'Method of inhibiting multiple organ failure in trauma patients by administration of superoxide dismutase' [patent_app_type] => 1 [patent_app_number] => 8/021722 [patent_app_country] => US [patent_app_date] => 1993-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2079 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/362/05362492.pdf [firstpage_image] =>[orig_patent_app_number] => 021722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3488107 [patent_doc_number] => 05470734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Recombinant herpesvirus of turkeys and live vector vaccines derived thereof' [patent_app_type] => 1 [patent_app_number] => 8/018489 [patent_app_country] => US [patent_app_date] => 1993-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8676 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470734.pdf [firstpage_image] =>[orig_patent_app_number] => 018489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657447 [patent_doc_number] => 05591631 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Anthrax toxin fusion proteins, nucleic acid encoding same' [patent_app_type] => 1 [patent_app_number] => 8/021601 [patent_app_country] => US [patent_app_date] => 1993-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17990 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591631.pdf [firstpage_image] =>[orig_patent_app_number] => 021601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610982 [patent_doc_number] => 05565338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor' [patent_app_type] => 1 [patent_app_number] => 8/142333 [patent_app_country] => US [patent_app_date] => 1993-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14798 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565338.pdf [firstpage_image] =>[orig_patent_app_number] => 142333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3020117 [patent_doc_number] => 05326749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-05 [patent_title] => 'Macrophage activating factor from vitamin D binding protein' [patent_app_type] => 1 [patent_app_number] => 8/000320 [patent_app_country] => US [patent_app_date] => 1993-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6530 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/326/05326749.pdf [firstpage_image] =>[orig_patent_app_number] => 000320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591701 [patent_doc_number] => 05496924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Fusion protein comprising an interleukin-2 fragment ballast portion' [patent_app_type] => 1 [patent_app_number] => 8/194545 [patent_app_country] => US [patent_app_date] => 1992-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 8674 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496924.pdf [firstpage_image] =>[orig_patent_app_number] => 194545 [rel_patent_id] =>[rel_patent_doc_number] =>)